In summary, we found that administering CJE to db/db mice at 200 mg/kg improved fasting blood glucose, serum insulin, serum leptin, and HOMA-IR levels, indicating a potential improvement in insulin resistance. The gene discussed is LEP; the disease is Insulin resistance.